Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Other Accumulated Expenses (2014 - 2015)

Minerva Neurosciences' (NERV) quarterly Other Accumulated Expenses came in at $1.1 million in Q2 2015, up 1310.0% on a QoQ basis from $76469.0 in Q1 2015.

Analysis

Minerva Neurosciences (NERV) Other Accumulated Expenses (2014 - 2015) Analysis & Trends

Minerva Neurosciences (NERV) has 2 years of Other Accumulated Expenses data on file, last reported at $1.1 million in Q2 2015.

  • Quarterly Other Accumulated Expenses changed N/A year-over-year to $1.1 million in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $1.1 million (changed N/A YoY) and the FY2014 annual result came in at $1.2 million, changed N/A from the prior year.
  • Other Accumulated Expenses climbed to $1.1 million in Q2 2015, from $76469.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.2 million in Q4 2014 to a low of $76469.0 in Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Minerva Neurosciences 207.37 Mn 207.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 1.08 Mn
Mar 31, 2015 1.46 Mn
Dec 31, 2014 1.22 Mn
Sep 30, 2014 1.39 Mn